Intradermal Injection Market
Intradermal Injection Market by Method, Application, End User & Region | Forecast 2022 to 2032
Intradermal Injections Administration to Accelerate, given their extensive Applications in treating Chronic Diseases, as well as Aesthetic Procedures
Intradermal Injection Market Snapshot (2022 to 2032)
The global intradermal injection market is expected to surpass an impressive valuation of US$ 3,878 Million in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.8% from 2022 to 2032.
In recent years, technological advancements have led to the development of surgical approaches with the aim to minimize waste and achieve better results. The reusable intradermal devices result in low waste generation, having a net positive effect on the productivity of an economy.
Along with this, the results of several meta-analyses prove that intradermal delivery of drugs reduces the intensity of adverse events. The factors mentioned above indicate the favorable condition for the rapid growth of this segment in the future.
|
Report Attribute |
Details |
|
Expected Market Value (2022) |
US$ 3,878 Million |
|
Anticipated Forecast Value (2032) |
US$ 10,814.47 Million |
|
Projected Growth Rate (2022 to 2032) |
10.8% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2017 to 2021 Intradermal Injection Demand Analysis vs. Forecast 2022 to 2032
Over the past two decades, there has been an increase in the demand for intradermal injections. This is due to the rising incidence of diseases with a simultaneous increase in the use of intradermal vaccination and aesthetic procedures.
Furthermore, the growing burden of chronic diseases has led to a rise in the overall use of syringes, particularly disposable syringes, intradermal jet injectors, microinjections, and ballistic intradermal injection treatment and diagnostic purposes. The global demand for Intradermal Injections is projected to increase at a CAGR of 10.8% during the forecast period between 2022 and 2032, reaching a total of US$ 10,814.47 Million in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 8%.
Which are Some Prominent Drivers of the Intradermal Injection Market?
Growing Prevalence of Chronic Diseases, Increase in Aesthetic Surgical Procedures to Catalyse Intradermal Injection Uptake
The rising prevalence rate of tuberculosis is expected to promote the growth rate of the intradermal injection market. As per the data of WHO, tuberculosis is the 13th leading cause of death, and about 10 million cases of TB have been recorded every year, which resulted in a sudden rise in the diagnostic rate of TB during the last decade. This is one of the major factors that act as one of the leading reasons for increasing the intradermal injection market size of tuberculin syringes.
In addition to this, the number of aesthetic procedures is increasing rapidly in North America and Europe. The intradermal vaccination reduces the potential dose of antigens, improves the immune response, and decreases the anxiety associated with the vaccination. Moreover, aesthetic procedures are the leading segment of local aesthetic procedures, increasing the demand for intradermal injections.
Almost all vaccines require cold chain distribution and storage, which further limits resources or refrigerator space in a healthcare setting. Globally, approximately 17.4 million people are prone to rabies through animal bites annually. It occurs in more than 150 territories and countries, rabies is a viral disease that can cause encephalitis when transmitted to humans. Intradermal injections immensely help in lowering the cost of cell-derived vaccines for pre-exposure to rabies. The cost-savings with intradermal injections for rabies create immense opportunities for the intradermal injections market.
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
What are the Challenges Projected to be Faced by the Market?
Unfavorable Government Provisions to Hinder Market Growth
Despite the advantages shown through various clinical studies, there are various barriers that hinder the usage of intradermal injections. The major world economies across Europe, the United States, and other developed regions rely on single-dose formats and have government funding or private insurance for vaccination. Emerging markets are anticipated to favor multi-dose formats and are limited by availability and cost of supply.
Region-wise Insights
What Makes the United States the Largest Market for Intradermal Injection?
Increased Prevalence of Diseases to drive the adoption of intradermal Injection
According to the American Cancer Society’s 2022 report, over 1.9 million new cancers are expected to be recorded in the United States in 2022. Also, as per the same source, the risk of having cancer rises dramatically as one gets older, and in the United States, 80% of cancer patients are 55 or older, with 57% being 65 or older. These figures tell that the growing geriatric population is expected to have a significant positive impact on the growth of the market.
Not just this but according to the International Diabetes Federation’s report of December 2021, about 32.2 million people were living with diabetes in the United States in 2021, and this number is estimated to increase to 36.3 million by 2045. This expansion in the diabetes patient pool is expected to boost growth in intradermal injection in the United States.
Why is the United Kingdom Considered a Lucrative Region for the Intradermal Injection Market?
The Increasing Prevalence of Diabetes is Spurring Demand for Intradermal Injection
As per the International Diabetes Federation (IDF) Diabetes Atlas 2021, the age-adjusted comparative prevalence of diabetes in the United Kingdom for 2021, 2030, and 2045 were estimated as 6.3%, 7.0%, and 7.5% respectively. Therefore, the gradual rise in the prevalence of diabetes is expected to increase the market demand.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Category-wise Insights
Which Method Type Leads the Market for Intradermal Injection?
Normal Sized Needles to Lead the Method Type of Intradermal Injection
Based on the method, the intradermal injection market is segmented into normal-sized needles, short needles, and without needles. As per our research, normal-sized needles dominate the market, while the short-needle segment is estimated to register considerable growth.
By Application, Which Segment is Projected to Lead the Market?
Tuberculin Skin Test Segment is Estimated to Hold the Largest Share
Based on application, the market is segmented into tuberculin skin tests, allergy tests, local aesthetics, and others. The tuberculin skin test segment is estimated to hold the largest share of the market in 2022, accounting for 58% of total demand, while the local aesthetic segment is expected to register the highest CAGR during the forecast period.
Market Competition
Key players in the Intradermal Injection market are Becton Dickinson, Cardinal Health, West Pharmaceuticals Services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, and Hindustan Syringes and Medical Devices.
- In May 2022, Stevanato Group S.p.A. signed an exclusive agreement with leading medical device developer and manufacturer Owen Mumford Ltd. for its Aidaptus auto-injector. Adeptus is a 2-step, single-use auto-injector with a versatile design that accommodates both 1 mL and 2.25 mL prefilled glass syringes in the same base device.
- In May 2020, Takeda Pharmaceutical Company Limited received approval from the European Commission for the subcutaneous (SC) formulation of Entyvio (vedolizumab), a gut-selective biologic for use as maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD). Entyvio SC is available in both a pre-filled syringe and a pre-filled pen.
- Terumo Corporation is a pioneer in hypodermic needle innovation. The company offers a comprehensive platform of precision-engineered needle and needle stick prevention technologies ready for the most challenging applications and high-throughput processing environments. The company helps design and deliver safer, less painful injections to ensure the therapeutic success of the drug product. Some of its products include the Nanopass® 34G Needle for Pen Injectors, the Neolus Needles, SurGuard® Safety Hypodermic Needles, the SurGuard® 3 Safety Hypodermic Needles, and the Terumo 3-Part Syringe.
- In May 2021, Crossject announced further strengthening of its partnership with long-term collaborator Cenexi to ramp up industrial-scale manufacturing of the ZENEO® needle-free auto-injection. With this announcement, Cenexi strengthened its positioning on innovation and sterile manufacturing expertise thanks to its human-scale agility, and its recognized skills in pharmaceutical development.
Report Scope
|
Report Attribute |
Details |
|
Market Value in 2022 |
US$ 3,878 Million |
|
Market Value in 2032 |
US$ 10,814.47 Million |
|
Growth Rate |
CAGR of 10.8% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2017 to 2021 |
|
Forecast Period |
2022 to 2032 |
|
Quantitative Units |
Revenue in USD Billion and CAGR from 2022 to 2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the Intradermal Injection Market Industry Survey
Intradermal Injection Market by Method:
- Normal Sized Needles
- Short Needle
- Intradermal Microinjection
- Microneedle Arrays
- Tattoo Devices
- Without Needle
- Intradermal Liquid Jet Devices and
- Ballistic Intradermal Injectors
Intradermal Injection Market by Application:
- Tuberculin Skin Test
- Allergy Test
- Local Aesthetics
- Others
Intradermal Injection Market by End User:
- Hospitals
- Diagnostic Laboratories
- Academics and Research Institutes
- Others
Intradermal Injection Market by Region:
- North America
- Europe
- South Asia
- East Asia
- Oceania
- Latin America
- Middle East and Africa (MEA)
Frequently Asked Questions
What is the anticipated growth of the market Intradermal Injection until 2032?
FMI projects the global Intradermal Injection market to expand at a 10.8% value CAGR by 2032.
What is the estimated market value of the Intradermal Injection market expected in 2022?
The global Intradermal Injection market is estimated at a market value of US$ 2.5 Billion.
What is the estimated market value of the Intradermal Injection market expected in 2032?
The global Intradermal Injection market is expected to garner a market value of US$ 10814.47 Million.
Which region is forecast to be the most lucrative for Intradermal Injection market growth?
FMI has projected North America to be one of the key regions for the Intradermal Injection market.
Which are some prominent Intradermal Injection manufacturers?
Becton Dickinson, Cardinal Health, West Pharmaceuticals services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, and Hindustan Syringes and Medical Devices.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Method 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ million) Analysis By Method, 2017 to 2021 5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Method, 2022 to 2032 5.3.1. Normal Sized Needles 5.3.2. Short Needle 5.3.2.1. Intradermal Microinjection 5.3.2.2. Microneedle Arrays 5.3.2.3. Tattoo Devices 5.3.3. Without Needle 5.3.3.1. Intradermal Liquid Jet Devices 5.3.3.2. Ballistic Intradermal Injectors 5.4. Y-o-Y Growth Trend Analysis By Method, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Method, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ million) Analysis By Application, 2017 to 2021 6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2022 to 2032 6.3.1. Tuberculin Skin Test 6.3.2. Allergy Test 6.3.3. Local Aesthetics 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ million) Analysis By End User, 2017 to 2021 7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2022 to 2032 7.3.1. Hospitals 7.3.2. Diagnostic Laboratories 7.3.3. Academics And Research Institutes 7.3.4. Others 7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021 7.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2021 8.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2022 to 2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. Middle East and Africa (MEA) 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Method 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Method 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Method 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Method 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Method 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Method 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Method 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Method 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Method 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Method 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Method 14.2.3. By Application 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Method 14.3.3. By Application 14.3.4. By End User 14.4. Key Takeaways 15. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Method 15.2.3. By Application 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Method 15.3.3. By Application 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. The USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2021 16.1.2.1. By Method 16.1.2.2. By Application 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2021 16.2.2.1. By Method 16.2.2.2. By Application 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2021 16.3.2.1. By Method 16.3.2.2. By Application 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2021 16.4.2.1. By Method 16.4.2.2. By Application 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2021 16.5.2.1. By Method 16.5.2.2. By Application 16.5.2.3. By End User 16.6. The United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2021 16.6.2.1. By Method 16.6.2.2. By Application 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2021 16.7.2.1. By Method 16.7.2.2. By Application 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2021 16.8.2.1. By Method 16.8.2.2. By Application 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2021 16.9.2.1. By Method 16.9.2.2. By Application 16.9.2.3. By End User 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2021 16.10.2.1. By Method 16.10.2.2. By Application 16.10.2.3. By End User 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2021 16.11.2.1. By Method 16.11.2.2. By Application 16.11.2.3. By End User 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2021 16.12.2.1. By Method 16.12.2.2. By Application 16.12.2.3. By End User 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2021 16.13.2.1. By Method 16.13.2.2. By Application 16.13.2.3. By End User 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2021 16.14.2.1. By Method 16.14.2.2. By Application 16.14.2.3. By End User 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2021 16.15.2.1. By Method 16.15.2.2. By Application 16.15.2.3. By End User 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2021 16.16.2.1. By Method 16.16.2.2. By Application 16.16.2.3. By End User 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2021 16.17.2.1. By Method 16.17.2.2. By Application 16.17.2.3. By End User 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2021 16.18.2.1. By Method 16.18.2.2. By Application 16.18.2.3. By End User 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2021 16.19.2.1. By Method 16.19.2.2. By Application 16.19.2.3. By End User 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2021 16.20.2.1. By Method 16.20.2.2. By Application 16.20.2.3. By End User 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2021 16.21.2.1. By Method 16.21.2.2. By Application 16.21.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Method 17.3.3. By Application 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Becton Dickinson 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Cardinal Health 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. West Pharmaceuticals services 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Terumo Corporation 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Nanopass 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Pharmajet 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Idevax 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Enusung 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Crossject 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Hindustan Syringes 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ million) Forecast by Region, 2017 to 2032 Table 2: Global Market Value (US$ million) Forecast by Method, 2017 to 2032 Table 3: Global Market Value (US$ million) Forecast by Application, 2017 to 2032 Table 4: Global Market Value (US$ million) Forecast by End User, 2017 to 2032 Table 5: North America Market Value (US$ million) Forecast by Country, 2017 to 2032 Table 6: North America Market Value (US$ million) Forecast by Method, 2017 to 2032 Table 7: North America Market Value (US$ million) Forecast by Application, 2017 to 2032 Table 8: North America Market Value (US$ million) Forecast by End User, 2017 to 2032 Table 9: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2032 Table 10: Latin America Market Value (US$ million) Forecast by Method, 2017 to 2032 Table 11: Latin America Market Value (US$ million) Forecast by Application, 2017 to 2032 Table 12: Latin America Market Value (US$ million) Forecast by End User, 2017 to 2032 Table 13: Europe Market Value (US$ million) Forecast by Country, 2017 to 2032 Table 14: Europe Market Value (US$ million) Forecast by Method, 2017 to 2032 Table 15: Europe Market Value (US$ million) Forecast by Application, 2017 to 2032 Table 16: Europe Market Value (US$ million) Forecast by End User, 2017 to 2032 Table 17: South Asia Market Value (US$ million) Forecast by Country, 2017 to 2032 Table 18: South Asia Market Value (US$ million) Forecast by Method, 2017 to 2032 Table 19: South Asia Market Value (US$ million) Forecast by Application, 2017 to 2032 Table 20: South Asia Market Value (US$ million) Forecast by End User, 2017 to 2032 Table 21: East Asia Market Value (US$ million) Forecast by Country, 2017 to 2032 Table 22: East Asia Market Value (US$ million) Forecast by Method, 2017 to 2032 Table 23: East Asia Market Value (US$ million) Forecast by Application, 2017 to 2032 Table 24: East Asia Market Value (US$ million) Forecast by End User, 2017 to 2032 Table 25: Oceania Market Value (US$ million) Forecast by Country, 2017 to 2032 Table 26: Oceania Market Value (US$ million) Forecast by Method, 2017 to 2032 Table 27: Oceania Market Value (US$ million) Forecast by Application, 2017 to 2032 Table 28: Oceania Market Value (US$ million) Forecast by End User, 2017 to 2032 Table 29: MEA Market Value (US$ million) Forecast by Country, 2017 to 2032 Table 30: MEA Market Value (US$ million) Forecast by Method, 2017 to 2032 Table 31: MEA Market Value (US$ million) Forecast by Application, 2017 to 2032 Table 32: MEA Market Value (US$ million) Forecast by End User, 2017 to 2032
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ million) by Method, 2022 to 2032 Figure 2: Global Market Value (US$ million) by Application, 2022 to 2032 Figure 3: Global Market Value (US$ million) by End User, 2022 to 2032 Figure 4: Global Market Value (US$ million) by Region, 2022 to 2032 Figure 5: Global Market Value (US$ million) Analysis by Region, 2017 to 2032 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032 Figure 8: Global Market Value (US$ million) Analysis by Method, 2017 to 2032 Figure 9: Global Market Value Share (%) and BPS Analysis by Method, 2022 to 2032 Figure 10: Global Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032 Figure 11: Global Market Value (US$ million) Analysis by Application, 2017 to 2032 Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2022 to 2032 Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032 Figure 14: Global Market Value (US$ million) Analysis by End User, 2017 to 2032 Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 17: Global Market Attractiveness by Method, 2022 to 2032 Figure 18: Global Market Attractiveness by Application, 2022 to 2032 Figure 19: Global Market Attractiveness by End User, 2022 to 2032 Figure 20: Global Market Attractiveness by Region, 2022 to 2032 Figure 21: North America Market Value (US$ million) by Method, 2022 to 2032 Figure 22: North America Market Value (US$ million) by Application, 2022 to 2032 Figure 23: North America Market Value (US$ million) by End User, 2022 to 2032 Figure 24: North America Market Value (US$ million) by Country, 2022 to 2032 Figure 25: North America Market Value (US$ million) Analysis by Country, 2017 to 2032 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 28: North America Market Value (US$ million) Analysis by Method, 2017 to 2032 Figure 29: North America Market Value Share (%) and BPS Analysis by Method, 2022 to 2032 Figure 30: North America Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032 Figure 31: North America Market Value (US$ million) Analysis by Application, 2017 to 2032 Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032 Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032 Figure 34: North America Market Value (US$ million) Analysis by End User, 2017 to 2032 Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 37: North America Market Attractiveness by Method, 2022 to 2032 Figure 38: North America Market Attractiveness by Application, 2022 to 2032 Figure 39: North America Market Attractiveness by End User, 2022 to 2032 Figure 40: North America Market Attractiveness by Country, 2022 to 2032 Figure 41: Latin America Market Value (US$ million) by Method, 2022 to 2032 Figure 42: Latin America Market Value (US$ million) by Application, 2022 to 2032 Figure 43: Latin America Market Value (US$ million) by End User, 2022 to 2032 Figure 44: Latin America Market Value (US$ million) by Country, 2022 to 2032 Figure 45: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2032 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 48: Latin America Market Value (US$ million) Analysis by Method, 2017 to 2032 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Method, 2022 to 2032 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032 Figure 51: Latin America Market Value (US$ million) Analysis by Application, 2017 to 2032 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032 Figure 54: Latin America Market Value (US$ million) Analysis by End User, 2017 to 2032 Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 57: Latin America Market Attractiveness by Method, 2022 to 2032 Figure 58: Latin America Market Attractiveness by Application, 2022 to 2032 Figure 59: Latin America Market Attractiveness by End User, 2022 to 2032 Figure 60: Latin America Market Attractiveness by Country, 2022 to 2032 Figure 61: Europe Market Value (US$ million) by Method, 2022 to 2032 Figure 62: Europe Market Value (US$ million) by Application, 2022 to 2032 Figure 63: Europe Market Value (US$ million) by End User, 2022 to 2032 Figure 64: Europe Market Value (US$ million) by Country, 2022 to 2032 Figure 65: Europe Market Value (US$ million) Analysis by Country, 2017 to 2032 Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 68: Europe Market Value (US$ million) Analysis by Method, 2017 to 2032 Figure 69: Europe Market Value Share (%) and BPS Analysis by Method, 2022 to 2032 Figure 70: Europe Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032 Figure 71: Europe Market Value (US$ million) Analysis by Application, 2017 to 2032 Figure 72: Europe Market Value Share (%) and BPS Analysis by Application, 2022 to 2032 Figure 73: Europe Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032 Figure 74: Europe Market Value (US$ million) Analysis by End User, 2017 to 2032 Figure 75: Europe Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 77: Europe Market Attractiveness by Method, 2022 to 2032 Figure 78: Europe Market Attractiveness by Application, 2022 to 2032 Figure 79: Europe Market Attractiveness by End User, 2022 to 2032 Figure 80: Europe Market Attractiveness by Country, 2022 to 2032 Figure 81: South Asia Market Value (US$ million) by Method, 2022 to 2032 Figure 82: South Asia Market Value (US$ million) by Application, 2022 to 2032 Figure 83: South Asia Market Value (US$ million) by End User, 2022 to 2032 Figure 84: South Asia Market Value (US$ million) by Country, 2022 to 2032 Figure 85: South Asia Market Value (US$ million) Analysis by Country, 2017 to 2032 Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 88: South Asia Market Value (US$ million) Analysis by Method, 2017 to 2032 Figure 89: South Asia Market Value Share (%) and BPS Analysis by Method, 2022 to 2032 Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032 Figure 91: South Asia Market Value (US$ million) Analysis by Application, 2017 to 2032 Figure 92: South Asia Market Value Share (%) and BPS Analysis by Application, 2022 to 2032 Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032 Figure 94: South Asia Market Value (US$ million) Analysis by End User, 2017 to 2032 Figure 95: South Asia Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 97: South Asia Market Attractiveness by Method, 2022 to 2032 Figure 98: South Asia Market Attractiveness by Application, 2022 to 2032 Figure 99: South Asia Market Attractiveness by End User, 2022 to 2032 Figure 100: South Asia Market Attractiveness by Country, 2022 to 2032 Figure 101: East Asia Market Value (US$ million) by Method, 2022 to 2032 Figure 102: East Asia Market Value (US$ million) by Application, 2022 to 2032 Figure 103: East Asia Market Value (US$ million) by End User, 2022 to 2032 Figure 104: East Asia Market Value (US$ million) by Country, 2022 to 2032 Figure 105: East Asia Market Value (US$ million) Analysis by Country, 2017 to 2032 Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 108: East Asia Market Value (US$ million) Analysis by Method, 2017 to 2032 Figure 109: East Asia Market Value Share (%) and BPS Analysis by Method, 2022 to 2032 Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032 Figure 111: East Asia Market Value (US$ million) Analysis by Application, 2017 to 2032 Figure 112: East Asia Market Value Share (%) and BPS Analysis by Application, 2022 to 2032 Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032 Figure 114: East Asia Market Value (US$ million) Analysis by End User, 2017 to 2032 Figure 115: East Asia Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 117: East Asia Market Attractiveness by Method, 2022 to 2032 Figure 118: East Asia Market Attractiveness by Application, 2022 to 2032 Figure 119: East Asia Market Attractiveness by End User, 2022 to 2032 Figure 120: East Asia Market Attractiveness by Country, 2022 to 2032 Figure 121: Oceania Market Value (US$ million) by Method, 2022 to 2032 Figure 122: Oceania Market Value (US$ million) by Application, 2022 to 2032 Figure 123: Oceania Market Value (US$ million) by End User, 2022 to 2032 Figure 124: Oceania Market Value (US$ million) by Country, 2022 to 2032 Figure 125: Oceania Market Value (US$ million) Analysis by Country, 2017 to 2032 Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 128: Oceania Market Value (US$ million) Analysis by Method, 2017 to 2032 Figure 129: Oceania Market Value Share (%) and BPS Analysis by Method, 2022 to 2032 Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032 Figure 131: Oceania Market Value (US$ million) Analysis by Application, 2017 to 2032 Figure 132: Oceania Market Value Share (%) and BPS Analysis by Application, 2022 to 2032 Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032 Figure 134: Oceania Market Value (US$ million) Analysis by End User, 2017 to 2032 Figure 135: Oceania Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 137: Oceania Market Attractiveness by Method, 2022 to 2032 Figure 138: Oceania Market Attractiveness by Application, 2022 to 2032 Figure 139: Oceania Market Attractiveness by End User, 2022 to 2032 Figure 140: Oceania Market Attractiveness by Country, 2022 to 2032 Figure 141: MEA Market Value (US$ million) by Method, 2022 to 2032 Figure 142: MEA Market Value (US$ million) by Application, 2022 to 2032 Figure 143: MEA Market Value (US$ million) by End User, 2022 to 2032 Figure 144: MEA Market Value (US$ million) by Country, 2022 to 2032 Figure 145: MEA Market Value (US$ million) Analysis by Country, 2017 to 2032 Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 148: MEA Market Value (US$ million) Analysis by Method, 2017 to 2032 Figure 149: MEA Market Value Share (%) and BPS Analysis by Method, 2022 to 2032 Figure 150: MEA Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032 Figure 151: MEA Market Value (US$ million) Analysis by Application, 2017 to 2032 Figure 152: MEA Market Value Share (%) and BPS Analysis by Application, 2022 to 2032 Figure 153: MEA Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032 Figure 154: MEA Market Value (US$ million) Analysis by End User, 2017 to 2032 Figure 155: MEA Market Value Share (%) and BPS Analysis by End User, 2022 to 2032 Figure 156: MEA Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032 Figure 157: MEA Market Attractiveness by Method, 2022 to 2032 Figure 158: MEA Market Attractiveness by Application, 2022 to 2032 Figure 159: MEA Market Attractiveness by End User, 2022 to 2032 Figure 160: MEA Market Attractiveness by Country, 2022 to 2032
Recommendations
Explore Healthcare Insights
View Reports
